| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/08/2004 | CN1178686C Ointment for wound healing |
| 12/08/2004 | CN1178681C Notoginseng and pangolin scales tinea curing pill |
| 12/08/2004 | CN1178677C Buccal cordyceps lozenge and its preparing process |
| 12/08/2004 | CN1178666C Gypenoside drip pill, and preparing process thereof |
| 12/08/2004 | CN1178662C Oral 2-methyl-thieno-benzodiazepine formulation |
| 12/08/2004 | CN1178661C Use of brinzolamide to prevent visual field loss |
| 12/08/2004 | CN1178659C Madicament formulation with controlled release of active agent |
| 12/08/2004 | CN1178656C Pharmaceutical composition |
| 12/08/2004 | CN1178655C Water-miscible pharmaceutical compositions of paclitaxel |
| 12/08/2004 | CN1178654C Chloromycetin kibe ointment |
| 12/08/2004 | CN1178652C Mizoribine tablet with improved colour |
| 12/08/2004 | CN1178651C Lyophilized thioxanthenone anti-tumor agents |
| 12/08/2004 | CN1178650C Multiple unit controlled non-independent release pharmaceutical preparations and method for preparing same |
| 12/08/2004 | CN1178649C Copmound zinc undecylenate ointment for treating beriberi |
| 12/08/2004 | CN1178648C Use of H+, K+-ATPase inhibitors in preparing oral medicine for enhancing inhibition of gastric acid secretion |
| 12/08/2004 | CN1178642C Oral care compositions |
| 12/07/2004 | US6828453 Phospholipid-analogous compounds |
| 12/07/2004 | US6828415 Dissolving an oligopeptide, such as Bombesin-Antagonist, Protirelin, Somatostatin and Cetrorelix, in acetic acid; transferring the solution to water, and lyophilizing; treating female infertility; gonad protection |
| 12/07/2004 | US6828357 Polyhydroxyalkanoate compositions having controlled degradation rates |
| 12/07/2004 | US6828356 Immersing a polymeric demulcent in water, agitating to dissolve, materials handling; use for dry eye syndrome, eye disorders |
| 12/07/2004 | US6828351 Methods and compositions for regulating memory consolidation |
| 12/07/2004 | US6828346 In mixture with alpha-tocopherol; administering by mouth |
| 12/07/2004 | US6828336 Nicotine-containing, controlled release composition and method |
| 12/07/2004 | US6828334 Having high dissolution profile and in vivo enhanced bioavailability |
| 12/07/2004 | US6828308 Compositions and methods for the treatment or prevention of inflammation |
| 12/07/2004 | US6828306 Charged lipid compositions and methods for their use |
| 12/07/2004 | US6828301 Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 12/07/2004 | US6828299 Polyhydroxy glycopeptide derivatives |
| 12/07/2004 | US6828155 Method for evaluating lipid a analog-containing injections |
| 12/07/2004 | US6827951 Composition and method for smoke detoxification |
| 12/07/2004 | US6827947 Film coating |
| 12/07/2004 | US6827946 Compositions containing both sedative and non-sedative antihistamines |
| 12/07/2004 | US6827945 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections |
| 12/07/2004 | US6827944 Water soluble active material and polymer mixture |
| 12/07/2004 | US6827932 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 12/07/2004 | US6827702 Safety limits for closed-loop infusion pump control |
| 12/07/2004 | US6827250 Methods for hermetically sealing microchip reservoir devices |
| 12/07/2004 | CA2107516C Antithrombin iii preparation |
| 12/07/2004 | CA2034522C Delivery system comprising means for controlling internal pressure |
| 12/02/2004 | WO2004104292A2 Method for making antimicrobial polyester-containing articles with improved wash durability and articles made thereby |
| 12/02/2004 | WO2004104021A2 Controlled release of active agents utilizing repeat sequence protein polymers |
| 12/02/2004 | WO2004103815A1 Fluidization of particles for encapsulation in oral dosage pharmaceutical products |
| 12/02/2004 | WO2004103409A1 Antitumor agent and process for producing the same |
| 12/02/2004 | WO2004103408A2 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 12/02/2004 | WO2004103399A1 Use of ulinastatin for treating severe acute respiratory syndrome and pharmaceutical composition of ulinastatin |
| 12/02/2004 | WO2004103396A1 Compositions for enhanced mucosal delivery of interferon alpha |
| 12/02/2004 | WO2004103382A1 Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex |
| 12/02/2004 | WO2004103373A1 Ophthalmic solution containing quinolone antimicrobial compound |
| 12/02/2004 | WO2004103363A1 Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 12/02/2004 | WO2004103351A1 Carrier particles |
| 12/02/2004 | WO2004103350A1 Oral sustained release pharmaceutical composition |
| 12/02/2004 | WO2004103349A2 Breakable, controlled-release device comprising a preformed passage |
| 12/02/2004 | WO2004103348A2 Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
| 12/02/2004 | WO2004103347A2 Production of small particles |
| 12/02/2004 | WO2004103346A1 Pharmaceutical compositions of acitretin |
| 12/02/2004 | WO2004103345A2 Particles which are stabilised in size by diacid copolymer |
| 12/02/2004 | WO2004103344A1 Combination chemotherapy comprising a liposomal platinum complex |
| 12/02/2004 | WO2004103342A2 Injectable sustained release compositions |
| 12/02/2004 | WO2004103341A2 Dissolvable backing layer for use with a transmucosal delivery device |
| 12/02/2004 | WO2004103340A1 Water dispersible tablets of lamotrigine |
| 12/02/2004 | WO2004103339A2 Improved metered dose inhaler |
| 12/02/2004 | WO2004103338A1 Adhesives and film modifying compositions |
| 12/02/2004 | WO2004103337A1 Improvements in adhesives and their applications |
| 12/02/2004 | WO2004103336A2 Drug delivery system |
| 12/02/2004 | WO2004103315A2 Treatment of ophthalmic infections using antimicrobial peptides |
| 12/02/2004 | WO2004103311A2 Antibiotic composition |
| 12/02/2004 | WO2004103299A2 Compositions and methods for the treatment of cns injuries |
| 12/02/2004 | WO2004103291A2 Extended release compositions of proton pump inhibitor |
| 12/02/2004 | WO2004103277A2 Novel composition for hormonal balance and uses thereof |
| 12/02/2004 | WO2004103266A2 Protein kinase c peptides for use in withdrawal |
| 12/02/2004 | WO2004103260A2 Ternary and quaternary eutectic mixtures. |
| 12/02/2004 | WO2004103233A1 Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde |
| 12/02/2004 | WO2004103232A1 Dissolvable vaginal deodorizing films and methods of vaginal deodorizing utilizing pliable dissolvable film |
| 12/02/2004 | WO2004096263A3 Human serum albumin-free stabilized interferon liquid formulations |
| 12/02/2004 | WO2004082707A3 Stabilisation of growth hormones in solution |
| 12/02/2004 | WO2004082587A3 Stable lamotrigine pharmaceutical compositions and processes for their preparation |
| 12/02/2004 | WO2004080397A3 Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent |
| 12/02/2004 | WO2004080396A3 Liposomal curcumin for treatment of cancer |
| 12/02/2004 | WO2004073635A3 Compositions comprising a plurality of particles or agglomerates having a defined particle size |
| 12/02/2004 | WO2004071645A3 Method and apparatus for supercritical fluid assisted particle production |
| 12/02/2004 | WO2004071466A3 Manufacturing process for liposomal preparations |
| 12/02/2004 | WO2004071156A3 Use of edible acid in fast-dispersing pharmaceutical solid dosage forms |
| 12/02/2004 | WO2004064779A3 Use of nitroglycerin to relieve nocturnal muscle cramps |
| 12/02/2004 | WO2004060344A3 Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
| 12/02/2004 | WO2004058192A3 Reversible masking of liposomal complexes for targeted delivery |
| 12/02/2004 | WO2004056338A9 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 12/02/2004 | WO2004054499A3 Platinum aggregates and process for producing the same |
| 12/02/2004 | WO2004050027A3 Materials and methods for treating ocular-related disorders |
| 12/02/2004 | WO2004032825A3 Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax |
| 12/02/2004 | WO2004017897A3 Aripiprazole complex formulation and method |
| 12/02/2004 | WO2004010952A3 Methods and compositions for treatment of dermal conditions |
| 12/02/2004 | WO2003092640A8 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 12/02/2004 | WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 12/02/2004 | US20040243481 System and method for rapidly customizing design, manufacture and/or selection of biomedical devices |
| 12/02/2004 | US20040243106 Osmotic delivery device with membrane plug retention mechanism |
| 12/02/2004 | US20040242730 Stabilized particle dispersions containing nanoparticles |
| 12/02/2004 | US20040242729 Contains dispersed phase that comprises particles dispersed in the continuous phase; continuous phase comprises a liquid continuous phase and surface-modified inorganic nanoparticles; a pharmaceutical dispersion for administration to mammals |
| 12/02/2004 | US20040242682 Compositions comprising arginine and nitrates |
| 12/02/2004 | US20040242670 Dissolving mixture of crystalline and amorphous Atorvastatin calcium in a hydroxylic solvent, drying resulting solution to remove solvent,and isolating amorphous Atorvastatin calcium in pure form |
| 12/02/2004 | US20040242651 to gastrointestal systems, kidneys |